|1.||Kipper, S L: 3 articles (05/2001 - 03/2000)|
|2.||Palestro, Christopher J: 2 articles (04/2007 - 11/2003)|
|3.||Love, Charito: 2 articles (04/2007 - 11/2003)|
|4.||Thakur, M L: 2 articles (05/2001 - 03/2000)|
|5.||Rypins, E B: 2 articles (09/2000 - 03/2000)|
|6.||Rini, Josephine N: 1 article (04/2007)|
|7.||Yu, Alice K: 1 article (04/2007)|
|8.||Pugliese, Paul V: 1 article (04/2007)|
|9.||Tronco, Gene G: 1 article (04/2007)|
|10.||Bhargava, Kuldeep K: 1 article (04/2007)|
02/01/2002 - "This prospective, multicenter, open-label study evaluated the diagnostic efficacy and clinical impact of LeuTech scintigraphy for detecting appendicitis in patients with an equivocal presentation. "
02/01/2002 - "LeuTech is a convenient, safe, rapid, and sensitive imaging test for diagnosis of appendicitis and favorably impacts patient management in adult and pediatric patients with equivocal signs and symptoms."
02/01/2002 - "LeuTech identified 53 of 59 patients with appendicitis (90% sensitivity) and was negative in 122 of 141 patients without appendicitis (87% specificity). "
02/01/2002 - "The authors studied a promising new monoclonal antibody, 99mTc-labeled anti-CD 15 (LeuTech; Palatin Technologies, Inc., Princeton, NJ), which specifically targets neutrophils and may be used for imaging appendicitis. "
02/01/2002 - "99m Tc anti-CD 15 monoclonal antibody (LeuTech) imaging improves diagnostic accuracy and clinical management in patients with equivocal presentation of appendicitis."
01/01/2002 - "LeuTech is also being investigated in Phase II clinical trials for the diagnosis of osteomyelitis in 45 patients at four sites. "
11/01/2003 - "99mTc-fanolesomab is a radiolabeled imaging agent which is being developed by Palatin Technologies for use in the diagnosis of various infections, including appendicitis and osteomyelitis."
01/01/2002 - "LeuTech is planned to be evaluated for the detection of osteomyelitis secondary to joint replacements (such as hip replacement), postoperative abscesses, ulcerative colitis and other intra-abdominal infections (colitis, spleen or urinary tract). "
01/01/2002 - "LeuTech binds to neutrophils in vivo at the infection site. "
05/01/2001 - "LeuTech was injected directly, intravenously, and its efficacy in imaging infection in 46 consecutive patients was determined. "
05/01/2001 - "Imaging infection with LeuTech."
04/01/2007 - "99mTc-fanolesomab imaging, performed 18-30 h after injection, diagnosed prosthetic vascular graft infection safely and accurately (95%). "
04/01/2007 - "The objectives of this retrospective investigation were to determine the accuracy of 99mTc-fanolesomab, an antigranulocyte antibody, for diagnosing prosthetic vascular graft infection, ascertain optimum imaging times for this indication, and assess safety of this agent. "
|5.||Cross Infection (Nosocomial Infection)
01/01/2002 - "LeuTech is a fast (1h to obtain image), convenient (one-step injection), safe, effective (bright, clear images) and cost-effective diagnostic for existing and new nuclear imaging markets including chronic and acute indications such as appendicitis, ischaemic bowel, post-surgical infection and nosocomial infection. "
|1.||Dihydrotachysterol (AT 10)
|2.||Immunoglobulin M (IgM)
|4.||Technetium (Technetium 99m)